Article Sidebar
Main Article Content
Abstract
Background. Corona Virus Disease 2019 (COVID-19) is an acute respiratory infection caused by the Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2). Clinical symptoms depending on the clinical severity of the patient which consists of mild, moderate, severe and critical. In COVID-19 patients who recover, pulmonary fibrosis can occur, which can lead to impaired lung function. In addition, there are also long covid complaints such as shortness of breath, nausea, coughing.
Methods. The research design is an observational study. The study was conducted at the Lubuk Begalung Padang Health Center from January 2021 to March 2021. The study population was all mild, moderate to severe COVID-19 patients in the working area of the Lubuk Begalung Padang Health Center and experienced long covid symptoms.
Results. The average age of COVID-19 survivors in this study was 46 years with a higher prevalence of women than men. The results of the pulmonary vap examination of most of the respondents were within normal limits. The most common distribution of clinical severity in this study was mild. The most common symptoms of long covid are weakness and muscle aches.
Conclusion. No correlation was found between the clinical complaints of survivors with the clinical severity and lung function.
Keywords
Article Details
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
